Inherited Disease
News on Mendelian diseases, hereditary cancer, variant classification, cystic fibrosis testing and more.
The genetic testing and health intelligence firm will start trading on the Nasdaq Global Select Market on Friday under the ticker symbols SMFR and SMFRW.
The company has launched an updated test called AvaGen that returns diagnostic subtype results for corneal dystrophies and polygenic risk scores for keratoconus.
Centogene Q1 Revenues Grow More Than Fivefold Driven by COVID-19 Testing
Core diagnostic testing revenues were €6.4 million, down 15 percent year over year, while pharmaceutical revenues totaled €3.6 million, down 22 percent.
The German bioinformatics startup recently partnered with Genomics England and Genomenon as it seeks to accelerate and bring transparency to genetic testing processes.
Centogene, Alector Partner to ID Frontotemporal Dementia Patients With Genetic Mutations
The EFRONT study aims to enroll more than 3,000 FTD patients for genetic testing at centers in Belgium, Germany, Greece, Italy, Portugal, Spain, and Turkey.